Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF.
The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue.
In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World.
North America and Europe is the industry's leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015.
The global Contract Pharmaceutical Manufacturing market was 68700 million US$ in 2018 and is expected to 108800 million US$ by the end of 2025, growing at a CAGR of 5.9% between 2019 and 2025.
This report studies the Contract Pharmaceutical Manufacturing market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Contract Pharmaceutical Manufacturing in these regions, from 2014 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
By the product type, the market is primarily split into
By the end users/application, this report covers the following segments
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of Central & South America
Middle East & Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Contract Pharmaceutical Manufacturing market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.
To understand the structure of Contract Pharmaceutical Manufacturing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Contract Pharmaceutical Manufacturing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Contract Pharmaceutical Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Contract Pharmaceutical Manufacturing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Contract Pharmaceutical Manufacturing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contract Pharmaceutical Manufacturing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Raw material suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Contract Pharmaceutical Manufacturing market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.